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ABSTRACT
Accumulating evidence suggests that the aberrant taxonomic composition of gut
microbiota is one of the etiological factor in the development of obesity. With the
inherent plasticity of gut microbiota structure, it provides a new avenue for the
application ofbiotherapeutics to modulate the shifted structure ofmicrobiota in obesity.
Lately, much attention has been focused on probiotic as a biotherapeutics candidate for
obesity. In contrast, knowledge on the modulating effects of probiotic on the obese gut
microbiota structure is still limited and should be evaluated. The present study aims to
elucidate the inherent plasticity of gut microbiota and the dynamic response of the host
metabolism during the induction of high-fat-diet-induced obesity and upon the
amelioration of obesity by probiotics in obese rat models. Two probiotic candidates; (i)
single strain Lactobacillus casei strain Shirota (LAB13) and (ii) probiotic cocktail
LACTO-5™ (L. rhamnosus, L. acidophilus, B. subtilis, B. longum and S. thermophilus)
were supplemented to the obese rats at doses of 1 x 109 CFU per/day/rat for 12 weeks.
The probiotic treatment started after the induction of obesity using high fat diet (HFD,
60% fat). The heterogeneity of gut microbiota structure and its functional complement
genes were profiled from the faecal samples of rats from each intervention group
(n=3/group) using shotgun metagenomics sequencing. Phenotypically, the weight gain,
energy intake, subcutaneous fat, total fat weights, total cholesterol, leptin, ratio of TC
to HDL-c and leptin to adiponectin in obese rats were significantly reduced by the
supplementation of both probiotics. These confirmed the anti-obesity,
hypocholesterolemic and hypoleptinemia effects ofboth probiotics. The strain-specific
salutary effect was noted in the reduction of TO and ratio of TO to HDL-c by LAB 13.
Both probiotics shifted the HFD-modulated gut microbiota towards the lean structure
after the supplementation being given seven weeks after the induction of obesity.
Comparative analysis revealed that the abundances of 68 bacterial genera were altered
by HFD and probiotics. HFD uniquely modulated 21 genera, 17 of which were
promoted and positively correlated with at least one of the obese phenotypes in obese
control rats. Thus, these genera may be relevant to obesity. LAB 13 modulated 32
genera, the enrichment of 16 genera of which were correlated positively with the
ameliorated obese phenotypes. LACTO-5™ modulated five genera, of this, the
enrichment of genus Coxiella was positively correlated with the ameliorated obese
phenotypes. Out of this, three genera were also found reduced by LAB 13. The
occurrences of 13 out of 26 annotated functional categories were enriched in the HFD-
modulated gut microbiome; suggesting a relative higher metabolic capacity in the obese
gut microbiome. Whereas both probiotic-modulated and STD-modulated gut
microbiome had lower occurrences of several protein-coding genes for metabolism of
carbohydrate, lipids, and nutrient transport; suggesting a relative lower energy
harvesting capacity in comparison to the HFD microbiome. Metabolomics analysis
showed increment in bile acid synthesis and reduction in glycerophospholipid and fatty
acids metabolism after probiotic treatment. These had increased the lipid clearance in
body which improved the obese phenotypes. Results from this study suggest the salutary
effects ofprobiotic, in part, are mediated by the changes in the gut microbiota structure
and its metabolic capacities in host metabolism particularly bile acid biosynthesis. This
study proved the possible mechanistic links between gut microbial-host interactions and
its role in obesity.
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CHAPTER ONE 
INTRODUCTION 
1.1 BACKGROUND OF THE STUDY 
As poverty declines, prevalence of obesity has doubled in virtually every 
country in the world including Malaysia. According to the World Health Organization 
(WHO), this “Globesity” trend would pose a severe problem to public health and may 
exacerbate the cost of healm care. Therefore coneeﬂed efforts are ongoing to investigate 
and understand the factors as well as to identify effective strategies to prevent obesity 
and its comorbid conditions. Recent studies demonstrated that the gut microbiota plays 
a role in the pathogenesis of various diseases such as obesity, which includes several 
suggested compositions of obese-prone gut microbiome (Angelakjs at 21.1., 2015; 
Backhed, Lay, Sonnenbuxg, Peterson, & Gordon, 2005; Cani & Delzenne, 2009; 
Lecomte et a].. 2015; Vega & Grundy, 2013; Vyas & Ranganathan, 2012). 
Compelling evidences identiﬁed long-term dietary pattern as one of the main 
inﬂuences in shaping and giving a unique min—individual diversity of gut microbiota, 
thus predisposing the host to various health conditions (Ammugam et al., 2014). Given 
their inherent plasticity and importance to health, modulation of the peltubated gut 
microbiota could be proposed as one of the non-invasive personalized therapy to 
ameliorate diseases such as obesity (Cani & Delzenne, 2009, 2011; Chen, G110, & 
Zhang, 2014). 
One ofthe , r ’ hin-‘nm , ' tools for ‘ ‘ inn is Pl L' ' based on 
their widely claimed health beneﬁts in ameliorating obesity through its 
L“ L . 1 ' hyper‘ r ‘ ‘ and hypnl' " ' effects (Aronsson et £11., 
2010; Ramasamy, Shafawi, Mani, Ho, & Abdul Majeed, 2012; Tsai, Chang, & Pan, 
2014; C. Wu et al., 2015). Therefore, based on their natural choluteml-lowering ability, 
probiotics are emerging as a promising biotherapeutic tool to combat obesity. 
However, cum-mt studies on the efﬁcacy of probiotics in modulating the gut 
microbiota as a biotherapeutic strategy for obesity are no‘ extensive. The modulating 
effects of probiotics on gut microbima was evaluated on a limited number of gut 
microbiota species using either traditional culture-based methods or targeted molecular
